MeSH term
Frequency | Condition_Probility | Humans | 199 | 0.0 |
3T3 Cells | 12 | 0.0 |
5' Untranslated Regions | 3 | 2.0 |
Animals | 168 | 0.0 |
Base Sequence | 25 | 0.0 |
Cell Line | 42 | 0.0 |
DNA/genetics | 2 | 0.0 |
Eukaryotic Initiation Factor-4E | 123 | 87.0 |
In Vitro | 15 | 0.0 |
Jurkat Cells | 7 | 0.0 |
Lymphocyte Activation | 3 | 0.0 |
Mice | 59 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 10 | 0.0 |
Molecular Sequence Data | 58 | 0.0 |
Peptide Initiation Factors/metabolism | 30 | 55.0 |
Protein Biosynthesis | 41 | 2.0 |
RNA, Messenger/genetics/metabolism | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 195 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 136 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Antiviral Agents/pharmacology | 2 | 3.0 |
Blotting, Western | 31 | 0.0 |
Cell Survival | 5 | 0.0 |
Dose-Response Relationship, Drug | 10 | 0.0 |
Eukaryotic Initiation Factor-4E/*genetics/metabolism | 3 | 100.0 |
Genetic Vectors | 6 | 0.0 |
Phenotype | 5 | 0.0 |
Plasmids/metabolism | 6 | 0.0 |
*Protein Biosynthesis | 46 | 9.0 |
RNA, Messenger/metabolism | 28 | 0.0 |
Transfection | 31 | 0.0 |
Tumor Cells, Cultured | 27 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 9 | 1.0 |
Carrier Proteins/metabolism | 33 | 4.0 |
Cell Cycle | 3 | 0.0 |
Cell Division | 10 | 0.0 |
Chromones/pharmacology | 6 | 2.0 |
Flow Cytometry | 4 | 0.0 |
G1 Phase | 2 | 0.0 |
Hela Cells | 30 | 0.0 |
Immunoblotting | 16 | 0.0 |
Models, Biological | 19 | 0.0 |
Morpholines/pharmacology | 6 | 2.0 |
Mutation | 15 | 0.0 |
Phosphoproteins/metabolism | 52 | 8.0 |
Precipitin Tests | 12 | 0.0 |
Protein Kinases/*metabolism | 8 | 2.0 |
Rats | 44 | 0.0 |
Ribosomal Protein S6 Kinases/*metabolism | 5 | 20.0 |
Signal Transduction | 21 | 0.0 |
Sirolimus/pharmacology | 13 | 17.0 |
Time Factors | 21 | 0.0 |
Up-Regulation | 3 | 0.0 |
Hamsters | 16 | 0.0 |
Hydrogen Peroxide/*pharmacology | 2 | 3.0 |
Osmolar Concentration | 2 | 0.0 |
Peptide Initiation Factors/*metabolism | 43 | 74.0 |
Phosphorylation/drug effects | 21 | 2.0 |
Protein Binding/drug effects/physiology | 2 | 5.0 |
Protein Biosynthesis/*drug effects | 9 | 29.0 |
Protein Synthesis Inhibitors/pharmacology | 8 | 2.0 |
Ribosomal Protein S6 Kinases/drug effects/metabolism | 2 | 66.0 |
p38 Mitogen-Activated Protein Kinases | 9 | 1.0 |
Carrier Proteins/*physiology | 3 | 1.0 |
Enzyme Inhibitors/pharmacology | 19 | 0.0 |
*Eukaryotic Initiation Factors | 11 | 52.0 |
Phosphoproteins/*physiology | 3 | 3.0 |
Phosphorylation | 114 | 1.0 |
Protein Binding/genetics | 3 | 1.0 |
Protein Kinases/physiology | 3 | 6.0 |
Stress | 2 | 3.0 |
Amino Acid Sequence | 56 | 0.0 |
Carrier Proteins/*chemistry/*metabolism | 3 | 6.0 |
Crystallography, X-Ray | 4 | 0.0 |
Electrostatics | 3 | 2.0 |
Eukaryotic Initiation Factor-4G | 45 | 86.0 |
Methylation | 2 | 0.0 |
Models, Molecular | 10 | 0.0 |
Peptide Initiation Factors/*chemistry/*metabolism | 5 | 83.0 |
Phosphoproteins/*chemistry/*metabolism | 2 | 11.0 |
Protein Binding | 49 | 0.0 |
Protein Structure, Tertiary | 14 | 0.0 |
RNA Cap-Binding Proteins | 6 | 75.0 |
RNA Caps/*chemistry/*metabolism | 2 | 100.0 |
Structure-Activity Relationship | 5 | 0.0 |
Thermodynamics | 7 | 2.0 |
Apoptosis | 7 | 0.0 |
Cells, Cultured | 22 | 0.0 |
Cycloheximide/pharmacology | 7 | 1.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
Male | 50 | 0.0 |
Polyribosomes/metabolism | 4 | 14.0 |
Rabbits | 18 | 0.0 |
Recombinant Proteins/metabolism | 8 | 0.0 |
Ribosomal Proteins/metabolism | 2 | 15.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 3 | 3.0 |
Eukaryotic Initiation Factor-4G/*metabolism | 6 | 85.0 |
Sirolimus/*pharmacology | 10 | 31.0 |
Kidney | 4 | 1.0 |
Female | 28 | 0.0 |
Middle Aged | 14 | 0.0 |
Neoplasm Staging | 8 | 0.0 |
Predictive Value of Tests | 3 | 0.0 |
Prospective Studies | 2 | 0.0 |
Survival Analysis | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Kinetics | 16 | 0.0 |
Mutagenesis, Site-Directed | 11 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Protein Conformation | 6 | 0.0 |
RNA Caps/metabolism | 9 | 60.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 37 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Peptide Initiation Factors/*analysis/genetics | 2 | 100.0 |
Eukaryotic Initiation Factor-2/metabolism | 14 | 46.0 |
Protein Biosynthesis/drug effects/physiology | 2 | 100.0 |
Protein Synthesis Inhibitors/*pharmacology | 2 | 6.0 |
Insulin/*blood | 2 | 1.0 |
Muscle, Skeletal/*physiology | 4 | 4.0 |
Protein Biosynthesis/drug effects/*physiology | 3 | 75.0 |
Rats, Sprague-Dawley | 21 | 0.0 |
Ribosomal Protein S6 Kinases/metabolism | 19 | 26.0 |
Gene Expression | 5 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
Peptide Initiation Factors/*genetics | 9 | 36.0 |
Treatment Outcome | 6 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Comparative Study | 18 | 0.0 |
Eukaryotic Initiation Factor-4E/*biosynthesis | 4 | 100.0 |
Conserved Sequence | 6 | 0.0 |
Peptide Initiation Factors/*chemistry | 2 | 66.0 |
Protein Structure, Secondary | 3 | 0.0 |
RNA Cap Analogs/*chemistry | 3 | 100.0 |
Eukaryotic Cells | 5 | 11.0 |
Xenopus | 3 | 0.0 |
Amino Acid Motifs/physiology | 2 | 6.0 |
Caspases/*metabolism | 4 | 1.0 |
Eukaryotic Initiation Factor-4F | 18 | 75.0 |
Insulin/pharmacology | 8 | 2.0 |
Macromolecular Substances | 10 | 0.0 |
Sequence Deletion | 5 | 0.0 |
Models, Genetic | 9 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Carrier Proteins/*metabolism | 13 | 1.0 |
Phosphoproteins/*metabolism | 23 | 4.0 |
Arsenites/pharmacology | 4 | 21.0 |
COS Cells | 8 | 0.0 |
Centrifugation, Density Gradient | 2 | 0.0 |
Cercopithecus aethiops | 4 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Peptide Chain Initiation, Translational | 7 | 15.0 |
Peptide Initiation Factors/analysis/metabolism | 2 | 100.0 |
RNA-Binding Proteins/metabolism | 5 | 6.0 |
Carrier Proteins/chemistry/*metabolism | 2 | 2.0 |
Enzyme Activation | 11 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 5 | 0.0 |
Peptide Initiation Factors/chemistry/*metabolism | 6 | 85.0 |
Phosphoproteins/chemistry/*metabolism | 4 | 6.0 |
Serine/metabolism | 5 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Threonine/metabolism | 5 | 5.0 |
Cattle | 2 | 0.0 |
Enzyme Activation/drug effects | 5 | 0.0 |
*Protein Biosynthesis/drug effects | 4 | 66.0 |
Protein Kinase Inhibitors | 5 | 3.0 |
Protein Kinases/metabolism | 8 | 1.0 |
*Protein-Serine-Threonine Kinases | 12 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 11 | 0.0 |
Administration, Oral | 2 | 0.0 |
Leucine/*administration & dosage | 2 | 100.0 |
Liver/*physiology | 2 | 4.0 |
Rats, Wistar | 8 | 0.0 |
Ribosomal Protein S6 Kinases/*physiology | 2 | 40.0 |
Adult | 7 | 0.0 |
Eukaryotic Initiation Factor-4E/*metabolism | 12 | 92.0 |
Protein-Serine-Threonine Kinases/*metabolism | 8 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Ribosomal Protein S6 Kinases, 70-kDa/metabolism | 5 | 25.0 |
Risk Factors | 2 | 0.0 |
*Signal Transduction | 7 | 0.0 |
CHO Cells | 11 | 0.0 |
RNA, Messenger/genetics | 12 | 0.0 |
Binding Sites | 33 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 4 | 0.0 |
Protein Isoforms | 7 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Sequence Homology, Amino Acid | 21 | 0.0 |
Cyclin D1/genetics | 2 | 3.0 |
Liver/*metabolism | 4 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Amino Acid Substitution | 6 | 0.0 |
Glutathione Transferase/metabolism | 5 | 0.0 |
Peptide Initiation Factors/chemistry/genetics/*metabolism | 4 | 57.0 |
Plasmids | 3 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
RNA Caps/*metabolism | 10 | 62.0 |
Recombinant Proteins/chemistry/metabolism | 7 | 1.0 |
Serine | 2 | 2.0 |
Surface Plasmon Resonance | 2 | 1.0 |
Dimerization | 2 | 0.0 |
Insulin/*metabolism | 2 | 2.0 |
MAP Kinase Signaling System | 3 | 1.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 5 | 1.0 |
DNA Mutational Analysis | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 10 | 0.0 |
Isoelectric Focusing | 4 | 0.0 |
Peptide Mapping | 4 | 0.0 |
Ribosomes/metabolism | 8 | 18.0 |
Serine/chemistry | 4 | 2.0 |
Spectrometry, Fluorescence | 5 | 1.0 |
Threonine/chemistry | 4 | 5.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 3 | 1.0 |
Leucine/blood/*pharmacology | 2 | 100.0 |
Cell Extracts | 3 | 2.0 |
Endopeptidases/metabolism | 4 | 2.0 |
Luciferases/genetics/metabolism | 2 | 0.0 |
Peptide Initiation Factors/*chemistry/genetics/*metabolism | 5 | 83.0 |
Saccharomyces cerevisiae/genetics/growth & development | 2 | 15.0 |
Serine/*metabolism | 2 | 2.0 |
Circular Dichroism | 2 | 0.0 |
Escherichia coli | 3 | 0.0 |
Guanosine Triphosphate/metabolism | 4 | 1.0 |
Peptide Initiation Factors/biosynthesis/*chemistry | 2 | 100.0 |
Immunosorbent Techniques | 3 | 1.0 |
Insulin/*pharmacology | 11 | 5.0 |
Muscle Proteins/*biosynthesis | 7 | 38.0 |
Sepsis/*metabolism | 3 | 25.0 |
Genes, Reporter | 8 | 0.0 |
RNA Stability | 2 | 3.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Eukaryotic Initiation Factor-2B/metabolism | 7 | 87.0 |
Peptide Chain Initiation, Translational/*physiology | 2 | 100.0 |
Saccharomyces cerevisiae/metabolism | 3 | 2.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
eIF-2 Kinase/metabolism | 2 | 14.0 |
Cell-Free System | 5 | 1.0 |
*RNA Stability | 2 | 8.0 |
RNA, Messenger/*metabolism | 13 | 2.0 |
RNA-Binding Proteins/*metabolism | 5 | 5.0 |
Repressor Proteins/*metabolism | 5 | 2.0 |
Reticulocytes | 4 | 12.0 |
Cell Nucleus/metabolism | 7 | 0.0 |
Peptide Initiation Factors/genetics/metabolism | 6 | 100.0 |
Poly(A)-Binding Proteins | 7 | 33.0 |
RNA, Messenger/genetics/*metabolism | 4 | 3.0 |
Phosphoproteins/drug effects/metabolism | 2 | 25.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 3 | 3.0 |
Caspases/antagonists & inhibitors/metabolism | 3 | 3.0 |
*Eukaryotic Initiation Factor-4G | 3 | 30.0 |
Immunosuppressive Agents/*pharmacology | 3 | 1.0 |
Peptide Fragments/*metabolism | 2 | 1.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Glucose/*pharmacology | 2 | 2.0 |
Biological Transport | 3 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
*Nucleocytoplasmic Transport Proteins | 2 | 5.0 |
Protein Biosynthesis/*genetics | 3 | 13.0 |
RNA Caps | 6 | 50.0 |
*Cell Transformation, Neoplastic | 6 | 1.0 |
Dinucleoside Phosphates/metabolism | 3 | 12.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Fasting | 4 | 1.0 |
Food | 2 | 1.0 |
Muscle, Skeletal/*metabolism | 10 | 5.0 |
Mammals | 2 | 0.0 |
RNA Cap Analogs | 2 | 100.0 |
Ribosomes/*metabolism | 5 | 16.0 |
Transcription, Genetic | 10 | 0.0 |
Globins/genetics | 3 | 2.0 |
Mutagenesis | 4 | 0.0 |
Peptide Initiation Factors/genetics/*metabolism | 8 | 61.0 |
Signal Transduction/genetics | 2 | 0.0 |
Down-Regulation | 4 | 0.0 |
DNA, Complementary | 7 | 0.0 |
Gene Dosage | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Peptide Initiation Factors/*biosynthesis | 2 | 100.0 |
Antibiotics, Antineoplastic/*pharmacology | 2 | 1.0 |
Neoplasm Transplantation | 3 | 0.0 |
Casein Kinase II | 2 | 1.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 11 | 1.0 |
Cloning, Molecular | 17 | 0.0 |
Eukaryotic Initiation Factor-4E/*genetics | 3 | 100.0 |
Sequence Alignment | 9 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Carrier Proteins/chemistry/genetics/*physiology | 2 | 5.0 |
Cell Division/physiology | 3 | 0.0 |
Phosphoproteins/chemistry/genetics/*physiology | 2 | 28.0 |
Signal Transduction/*physiology | 5 | 0.0 |
Cross-Linking Reagents | 4 | 1.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Acute Disease | 2 | 0.0 |
Culture Media, Serum-Free | 4 | 1.0 |
Animals, Newborn | 3 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Myocardium/cytology/*metabolism | 2 | 4.0 |
Point Mutation | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 5 | 0.0 |
*Carrier Proteins | 50 | 8.0 |
Protein Biosynthesis/*physiology | 8 | 34.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 5 | 4.0 |
Epithelial Cells/metabolism | 3 | 0.0 |
Kidney Tubules, Proximal/cytology/*metabolism | 2 | 18.0 |
Tyrosine/metabolism | 3 | 0.0 |
Binding, Competitive | 2 | 0.0 |
RNA Caps/*genetics | 3 | 100.0 |
Protein Subunits | 2 | 0.0 |
RNA Caps/chemistry/*metabolism | 4 | 100.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 2 | 1.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Open Reading Frames | 3 | 0.0 |
Eukaryotic Initiation Factor-4E/metabolism | 15 | 83.0 |
Repressor Proteins/metabolism | 4 | 2.0 |
Binding, Competitive/genetics | 2 | 13.0 |
Codon, Initiator/genetics | 2 | 8.0 |
Flavonoids/pharmacology | 6 | 1.0 |
Mitogen-Activated Protein Kinases/physiology | 2 | 1.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 2 | 0.0 |
*Phosphotransferases (Alcohol Group Acceptor) | 2 | 16.0 |
Imidazoles/pharmacology | 5 | 2.0 |
Pyridines/pharmacology | 5 | 1.0 |
Protein Isoforms/metabolism | 2 | 1.0 |
Gene Deletion | 3 | 0.0 |
Peptide Initiation Factors/*genetics/*metabolism | 3 | 100.0 |
Phosphopeptides/chemistry | 2 | 10.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
Insulin/metabolism | 2 | 1.0 |
Swine | 2 | 0.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Glucocorticoids/*pharmacology | 3 | 1.0 |
Insulin/blood | 3 | 0.0 |
Amino Acids/pharmacology | 2 | 10.0 |
*Protein Kinases | 5 | 7.0 |
Signal Transduction/drug effects | 5 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Disease-Free Survival | 3 | 0.0 |
Prognosis | 5 | 0.0 |
Retrospective Studies | 6 | 0.0 |
Antigens, CD95/physiology | 2 | 2.0 |
Hydrolysis | 2 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
*Apoptosis/drug effects | 4 | 3.0 |
Etoposide/pharmacology | 3 | 2.0 |
Protein Biosynthesis/drug effects | 7 | 11.0 |
DNA Primers | 4 | 0.0 |
Recombinant Fusion Proteins/metabolism | 7 | 0.0 |
Homeodomain Proteins/genetics/*metabolism | 2 | 1.0 |
Cell Transformation, Neoplastic/*genetics | 2 | 1.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Head and Neck Neoplasms/*genetics/pathology | 2 | 6.0 |
Peptide Initiation Factors/biosynthesis/*genetics | 2 | 66.0 |
Precancerous Conditions | 2 | 11.0 |
Cell Line, Transformed | 6 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Heat | 3 | 0.0 |
Phosphotransferases/metabolism | 2 | 4.0 |
Cell Compartmentation | 2 | 0.0 |
Cell Fractionation | 3 | 1.0 |
Gene Library | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
Mice, Nude | 3 | 0.0 |
Vascular Endothelial Growth Factor A | 3 | 0.0 |
Vascular Endothelial Growth Factors | 3 | 0.0 |
Disease Progression | 4 | 0.0 |
Stomach Neoplasms/*metabolism/pathology/physiopathology | 2 | 100.0 |
Phosphoproteins/genetics/*metabolism | 4 | 2.0 |
Repressor Proteins/genetics/*metabolism | 3 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 3 | 0.0 |
Gene Expression Regulation, Enzymologic/drug effects | 2 | 1.0 |
Hypoglycemic Agents/*pharmacology | 4 | 9.0 |
Ribosomal Protein S6 Kinases/antagonists & inhibitors/metabolism | 2 | 40.0 |
Signal Transduction/physiology | 3 | 0.0 |
Amino Acids/*pharmacology | 4 | 17.0 |
PC12 Cells | 2 | 0.0 |
Phosphotransferases (Alcohol Group Acceptor)/metabolism | 3 | 4.0 |
Protein Binding/drug effects | 2 | 0.0 |
Insulin-Like Growth Factor I/pharmacology | 2 | 1.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Peptide Initiation Factors/chemistry/*genetics/*metabolism | 2 | 66.0 |
Phylogeny | 2 | 0.0 |
Recombinant Proteins/chemistry | 3 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Eukaryotic Initiation Factor-4F/metabolism | 3 | 100.0 |
Hydrogen Peroxide/pharmacology | 3 | 1.0 |
Peptides/chemistry | 4 | 1.0 |
Androstadienes/pharmacology | 4 | 1.0 |
Carrier Proteins/*genetics/metabolism | 3 | 1.0 |
RNA, Messenger/chemistry/*metabolism | 2 | 15.0 |
Molecular Structure | 2 | 0.0 |
*Nucleic Acid Conformation | 3 | 3.0 |
Molecular Weight | 4 | 0.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 2 | 1.0 |
Genes, myc | 5 | 1.0 |
Half-Life | 2 | 0.0 |
Staurosporine/pharmacology | 2 | 1.0 |
Peptide Initiation Factors/metabolism/*physiology | 3 | 100.0 |
Perfusion | 2 | 0.0 |
Eukaryotic Initiation Factor-4A | 3 | 20.0 |
Leucine/deficiency/pharmacology | 2 | 100.0 |
Muscle Proteins/biosynthesis | 2 | 50.0 |
Neoplasm Recurrence, Local | 3 | 0.0 |
Peptide Initiation Factors/*analysis | 3 | 75.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Okadaic Acid/pharmacology | 2 | 2.0 |
Fibroblast Growth Factor 2/*genetics | 2 | 10.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Phosphoproteins/chemistry/genetics/*metabolism | 3 | 7.0 |
RNA Caps/genetics/*metabolism | 4 | 100.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 2 | 2.0 |
Substrate Specificity | 2 | 0.0 |
Peptide Initiation Factors/*genetics/metabolism | 2 | 66.0 |
Proto-Oncogene Proteins c-myc/*physiology | 3 | 7.0 |
Cell Line, Tumor | 9 | 0.0 |
*Apoptosis | 2 | 0.0 |
Cell Transformation, Neoplastic | 5 | 0.0 |
United States | 2 | 0.0 |
Anisomycin/pharmacology | 2 | 6.0 |
Apoptosis/physiology | 2 | 0.0 |
Cyclin D1/metabolism | 2 | 1.0 |
Neoplasm Proteins/biosynthesis | 2 | 2.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 6 | 2.0 |
Muscle, Skeletal/drug effects/*metabolism | 2 | 10.0 |
Survival Rate | 2 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 2 | 0.0 |
*RNA Caps | 3 | 42.0 |
Subcellular Fractions | 2 | 1.0 |
Breast Neoplasms/*metabolism/pathology | 2 | 1.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Insulin Antagonists/*pharmacology | 2 | 40.0 |
Amino Acid Chloromethyl Ketones/pharmacology | 2 | 1.0 |
*Mitogen-Activated Protein Kinases | 5 | 1.0 |
Eating | 3 | 2.0 |
*Peptide Chain Initiation, Translational | 5 | 31.0 |
Peptide Chain Initiation, Translational/*drug effects | 2 | 66.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Reticulocytes/metabolism | 2 | 2.0 |
Cell Differentiation | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Eukaryotic Initiation Factor-4G/metabolism | 6 | 75.0 |
Tissue Distribution | 3 | 0.0 |
Glutathione Transferase/genetics/metabolism | 2 | 1.0 |
Saccharomyces cerevisiae/*genetics | 2 | 1.0 |
Amino Acids/*metabolism | 2 | 5.0 |
Phosphoproteins/*chemistry/metabolism | 2 | 20.0 |
*Protein Folding | 2 | 1.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
Polyenes/pharmacology | 5 | 19.0 |
Sirolimus | 7 | 16.0 |
Phosphoproteins/*genetics | 3 | 1.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Cell Division/*genetics | 2 | 3.0 |
Child, Preschool | 2 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Solutions | 2 | 1.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 3 | 0.0 |
Species Specificity | 3 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Guanosine Diphosphate/metabolism | 2 | 1.0 |
*Genes, Structural | 2 | 0.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Ribosomal Protein S6 Kinases | 3 | 12.0 |
Carrier Proteins/physiology | 2 | 1.0 |
Eukaryotic Initiation Factor-4E/physiology | 2 | 66.0 |
Phosphoproteins/physiology | 3 | 5.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Phosphoproteins/genetics/metabolism | 2 | 2.0 |
Ribosomal Protein S6 Kinases, 90-kDa/metabolism | 4 | 36.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Protein Biosynthesis/physiology | 2 | 18.0 |
Eukaryotic Initiation Factor-4E/genetics/*metabolism | 2 | 100.0 |
Ribosomal Protein S6 Kinases, 70-kDa/*metabolism | 3 | 30.0 |
Proteins/metabolism | 2 | 0.0 |
Receptor, Insulin/metabolism | 3 | 3.0 |
3T3-L1 Cells | 2 | 8.0 |
Signal Transduction/drug effects/physiology | 3 | 1.0 |
NIH 3T3 Cells | 3 | 1.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Purines/pharmacology | 3 | 5.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Alanine/chemistry | 2 | 2.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
Eukaryotic Initiation Factor-4E/chemistry/*metabolism | 2 | 100.0 |
Eukaryotic Initiation Factor-4E/*chemistry/metabolism | 2 | 100.0 |
Eukaryotic Initiation Factor-4G/genetics/metabolism | 2 | 66.0 |
Injections, Intraperitoneal | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
MAP Kinase Signaling System/*physiology | 2 | 2.0 |
Aniline Compounds/pharmacology | 2 | 18.0 |
Protein Kinases/genetics/*metabolism | 2 | 2.0 |
Amino Acid Motifs | 2 | 0.0 |
Insulin-Like Growth Factor I/*pharmacology | 2 | 1.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Exercise/*physiology | 2 | 0.0 |
RNA Caps/chemistry/metabolism | 3 | 100.0 |
Protein Folding | 3 | 0.0 |
Endothelium, Vascular/cytology/*drug effects/metabolism | 2 | 2.0 |
Insulin/*physiology | 2 | 4.0 |
